UK Parliament / Open data

Human Fertilisation and Embryology Bill [Lords]

It is certainly possible, but it is also possible that new primary legislation could be brought before the House if that was felt necessary, as happened over human reproductive cloning. In that case it was felt necessary to reassure the public through primary legislation that something that was not envisaged and not possible would also be illegal. So, we are not in an ““It's now or nothing”” situation. Let me also deal with the issue of definitions. A huge amount of effort has been put in, especially by Members of the House of Lords and the Government Bill team, to try to find an appropriate definition. A tribute must be paid to Lord Mackay in particular, who has struggled, even though he was not necessarily a huge fan of the legislation to start with, to find a way to deal with the issue. The Government have engaged on the subject and done the best that they feel they can. It would not be appropriate for the Government to argue—indeed, I hope that the Minister does not argue—that the list is definitive. However, it is as good as one can get while preserving the ability of scientists to do the research in a way that will be regulated. There is no scientist in the country who does not understand that such research will have to apply to the HFEA under one of the categories set out in the Bill. There are two potential gaps, one of which the hon. Member for Enfield, Southgate mentioned. Proposed new section 4A(6)(e) talks about an embryo that does not fall within paragraphs (a) to (d) which"““contains both nuclear or mitochondrial DNA of a human and nuclear or mitochondrial DNA of an animal…but in which the animal DNA is not predominant.””" The key question, however, is at what point we are talking about the animal DNA not being pre-dominant, because that could vary. The hon. Gentleman rightly said that the scientists pointed that out in evidence to the Committee. That is not a secret, which is why it would be appropriate for the Government not to recognise that the list is not perfect. Indeed, it cannot be perfect, but I argue that it is good enough. That is one problem. The second problem is that even if the hon. Gentleman is right that the tetraploidal complementation process that he mentioned falls outwith the provisions, his amendment does not solve the problem. It is quite possible to have complementation that does not involve tetraploid cells. One could inject into a more developed, normal diploid embryo a less developed human embryo, which would then predominate, causing the original embryo to become the extra-embryonic endoderm and the trophectoderm—the stuff that forms the placenta—as has been done in mice. His amendment does not refer to such an entity, however. So the hon. Gentleman is merely demonstrating that the clause is never going to be perfect, but it is clear that anyone attempting to implant an entity which arguably does not fall within the definition in clause 4 will have to apply for a licence to the animal procedures committee to implant it. When I spoke to the hon. Gentleman outside the Chamber, he conceded, I hope it is fair to say, in answer to my question if one created an entity with human cells in an animal envelope—I do not believe that that is likely outside HFEA regulation in any event, for reasons that the Minister will explain—a licence would still be needed to implant it into an animal. One cannot just grab a pig from a farm, drag it into a lab and implant something into it without a licence.
Type
Proceeding contribution
Reference
481 c368-9 
Session
2007-08
Chamber / Committee
House of Commons chamber
Back to top